RLMD
Relmada Therapeutics Inc
Price:  
4.44 
USD
Volume:  
1,264,305.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

RLMD Stock Forecast & Price Target

RLMD Stock Price Forecast

The average stock forecast for Relmada Therapeutics Inc (RLMD) in the next 12 months is 12.92 USD. This price target corresponds to an upside of 195.65%. The range of stock forecasts for RLMD is 9.09 - 19.95 USD. Based on the ratings of 11 analysts, the consensus recommendation for RLMD is BUY.
Target Low Average Median High
Price (USD) 9.09 12.92 12.24 19.95
Upside 108.01% 195.65% 180.09% 356.52%

Recommendation Trends

The latest consensus rating for RLMD is "BUY". This is the average recommendation of 11 analysts: 0 strong sell, 0 sell, 1 hold, 6 buy, 4 strong buy. In the previous period, 12 analysts also majorly recommmended "BUY" for RLMD.

RLMD Financial Stock Forecast

Revenue This Year
-M
from -M
Revenue Next Year
-M
from -M
EPS This Year
-0.66
21.31%
from -0.55
EPS Next Year
-0.83
25.71%
from -0.66